View Transcript
Episode Description
Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as Non-alcoholic fatty liver disease (NAFLD), is estimated to affect up to 1 in 5 people in the UK. Rates are increasing with rising levels of obesity. Although most cases of MASLD are linked to excess weight, you can develop the disease if you have a healthy weight.
In this podcast, Dr Thomas Round talks to Dr Helen Jarvis, a GP and Clinical lecturer and researcher at Newcastle University with an interest in liver disease about fatty liver disease in primary care.
In this podcast, Dr Thomas Round talks to Dr Helen Jarvis, a GP and Clinical lecturer and researcher at Newcastle University with an interest in liver disease about fatty liver disease in primary care.
- RCGP. EKU Module on Diagnosis and management of non-alcoholic fatty liver disease. May 2024.
- RCGP. Liver Toolkit. June 2025
- BSG. BSG Guidelines on the management of abnormal liver blood tests. December 2021.
- NICE. NG49. Non-alcoholic fatty liver disease (NAFLD): assessment and management. July 2016 (last reviewed October 2024).